Bariatric surgery and GLP-1 drugs are associated with reductions in fat mass and a shift in body composition toward a higher ...
As California ends Medicaid coverage for GLP-1 weight loss drugs like Wegovy and Zepbound, experts say the state's advice to ...
Injectable weight loss drugs such as semaglutide and tirzepatide have attracted huge attention, but new real-world data suggest they deliver far less weight loss than surgery outside clinical trials.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback